1. Home
  2. PLSE vs ICHR Comparison

PLSE vs ICHR Comparison

Compare PLSE & ICHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pulse Biosciences Inc (DE)

PLSE

Pulse Biosciences Inc (DE)

HOLD

Current Price

$26.93

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Ichor Holdings

ICHR

Ichor Holdings

HOLD

Current Price

$92.70

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLSE
ICHR
Founded
2014
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.6B
IPO Year
2015
2016

Fundamental Metrics

Financial Performance
Metric
PLSE
ICHR
Price
$26.93
$92.70
Analyst Decision
Buy
Strong Buy
Analyst Count
1
6
Target Price
$22.00
$49.50
AVG Volume (30 Days)
271.1K
1.1M
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$947,652,000.00
Revenue This Year
$840.00
$20.51
Revenue Next Year
$287.54
$17.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.61
52 Week Low
$12.56
$13.15
52 Week High
$28.53
$101.65

Technical Indicators

Market Signals
Indicator
PLSE
ICHR
Relative Strength Index (RSI) 58.41 61.95
Support Level $23.94 $60.40
Resistance Level $27.82 N/A
Average True Range (ATR) 1.71 6.96
MACD -0.03 1.10
Stochastic Oscillator 64.13 76.18

Price Performance

Historical Comparison
PLSE
ICHR

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.

About ICHR Ichor Holdings

Ichor Holdings Ltd designs, engineers, and manufactures critical fluid delivery subsystems and components mainly for semiconductor capital equipment, along with solutions for defense/aerospace and medical industries. Its product portfolio includes gas and chemical delivery subsystems that enable precise delivery, monitoring, and control of specialized gases and reactive liquid chemistries used in semiconductor manufacturing processes such as etch, electroplating, and cleaning. The company also provides precision-machined components, weldments, e-beam and laser-welded components, as well as precision vacuum and hydrogen brazing. Geographically, the company operates across the United States, Singapore, Europe, and other regions, with Singapore contributing the majority of revenue.

Share on Social Networks: